KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Acquisitions (2021)

Twist Bioscience (TWST) has disclosed Acquisitions for 1 consecutive years, with $8.2 million as the latest value for Q4 2021.

  • On a quarterly basis, Acquisitions changed N/A to $8.2 million in Q4 2021 year-over-year; TTM through Sep 2022 was $8.2 million, a N/A change, with the full-year FY2022 number at $8.2 million, up 1589.44% from a year prior.
  • Acquisitions was $8.2 million for Q4 2021 at Twist Bioscience, up from $483000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $8.2 million in Q4 2021 to a low of $483000.0 in Q2 2021.